Emergex snags over $11 mln Series A

UK-based Emergex, a developer of set-point vaccines to prevent serious infectious diseases, has raised over $11 million in Series A funding.

UK-based Emergex, a developer of set-point vaccines to prevent serious infectious diseases, has raised over $11 million in Series A funding. Vickers Venture Partners led the round. In addition to the funding, Dr. Finian Tan, chairman of Vickers Venture Partners, will join the Emergex board as a non-executive director.

Source: Press Release